Drug
Bismuth subsalicylate clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 7
Centers for Disease Control and Prevention (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Cincinnati (1) · Fatih Sultan Mehmet Training and Research Hospital (1) · M.D. Anderson Cancer Center (1) · Biogen (1) · Bassett Healthcare (1)
Often tested with
Tested in the same studies.
Amoxicillin (1) · Clarithromycin (1) · Metronidazole (1) · Omeprazole (1) · Tetracycline (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses bismuth subsalicylate is read from its arms, and is right about nine times in ten.
Testing it · 8
- Bismuth Subsalicylate's Role in the Prevention of Travelers' DiarrheaTerminatedPhase 3Centers for Disease Control and PreventionNCT03535272Written as Bismuth subsalicylate
- Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT05930197Written as Bismuth subsalicylate
- Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)CompletedPhase 4University of CincinnatiNCT04811339Written as Bismuth Subsalicylate 262 milligram (mg) Oral Tablet, Chewable
- THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMYCompletedPhase 4Fatih Sultan Mehmet Training and Research HospitalNCT03757650Written as Bismuth Subsalicylate
- Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--PakistanCompletedNot applicableCenters for Disease Control and PreventionNCT02047162Written as Bismuth subsalicylate
- Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the StomachCompletedPhase 2M.D. Anderson Cancer CenterNCT00002682Written as Bismuth Subsalicylate
- Use of Bismuth Subsalicylate in Clostridium Difficile ColitisWithdrawnPhase 4Bassett HealthcareNCT03592082Written as Bismuth Subsalicylate
- PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice DailyCompletedPhase 1BiogenNCT01915901Written as bismuth subsalicylate (Pepto-Bismol®)
Given in every arm · 1 — bismuth subsalicylate is usual care beside what is tested
As the comparator · 1 — what is tested is compared with bismuth subsalicylate
Codes
What other systems call bismuth subsalicylate · ClinicalTrials.gg INT002633
- MeSH (NLM) C015715bismuth subsalicylateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 62TEY51RR1BISMUTH SUBSALICYLATEConfirmed FDA, NLM, Wikidata
- RxNorm 19478Confirmed FDA, Wikidata
- Wikidata Q81890bismuth subsalicylateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1020Bismuth SubsalicylateConfirmed FDA, Wikidata
- DrugBank DB01294One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C015715 | bismuth subsalicylate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 62TEY51RR1 | BISMUTH SUBSALICYLATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 19478 | — | Confirmed FDA, Wikidata |
| Wikidata | Q81890 | bismuth subsalicylate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1020 | Bismuth Subsalicylate | Confirmed FDA, Wikidata |
| DrugBank | DB01294 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.